Several cutting-edge technologies are employed in the screening process:
High-Throughput Screening (HTS): This technology allows for the rapid testing of thousands to millions of compounds against a target to identify potential inhibitors or modulators. Next-Generation Sequencing (NGS): NGS technologies provide comprehensive genomic data that can reveal mutations and gene expression profiles specific to cancer. CRISPR-Cas9: This gene-editing technology is used to knock out specific genes to study their function in cancer cells. Mass Spectrometry: Used in proteomics to identify and quantify proteins in cancer cells, providing insights into potential drug targets.
